Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Immunogenicity and Safety of Rotavac® and Rotasiil® Administered in an Interchangeable Dosing Schedule among Healthy Indian Infants: A Multicentric, Phase IV, Open-Labeled, Randomized, Controlled Trial - RVICS

Trial Profile

Immunogenicity and Safety of Rotavac® and Rotasiil® Administered in an Interchangeable Dosing Schedule among Healthy Indian Infants: A Multicentric, Phase IV, Open-Labeled, Randomized, Controlled Trial - RVICS

Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Nov 2018

At a glance

  • Drugs Bovine rotavirus vaccine reassortant (Primary) ; Rotavirus vaccine (Primary)
  • Indications Rotavirus infections
  • Focus Pharmacodynamics
  • Acronyms RVICS
  • Most Recent Events

    • 13 Nov 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top